Zydus Sees Revlimid Generic Revenues Beyond Q4 As It Waits For Antitrust Suit To Play Out

Acquires Teva Group API Maker Watson

 
• By Vibha Ravi
  
Growth Story
Zydus Is Planning For Growth, But Will Generic Revlimid Cast A Shadow • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip